4//SEC Filing
DA32 Sponsor LLC 4
Accession 0000899243-21-032222
CIK 0001863294other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 7:37 PM ET
Size
7.1 KB
Accession
0000899243-21-032222
Insider Transaction Report
Form 4
DA32 Sponsor LLC
10% Owner
Transactions
- Other
Class B Common Stock, par value $0.0001 per share
2021-08-05−701,250→ 4,465,000 total→ Class A Common Stock (701,250 underlying)
Footnotes (3)
- [F1]DA32 Sponsor LLC (the "Reporting Person") is the record holder of the securities reported herein. Deerfield Partners, L.P., ARCH Venture Fund XI, L.P. and Section 32 Fund 3, LP are the managing members of the Reporting Person, and share voting and investment discretion with respect to the common stock held of record by the Reporting Person. Each of the foregoing entities disclaim beneficial ownership of these shares except to the extent of any pecuniary interest therein.
- [F2]The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Shares" in the Issuer's Registration Statement on Form S-1 (File No. 333-257679) (the "Registration Statement") and have no expiration date.
- [F3]On August 5, 2021, the Reporting Person forfeited 701,250 shares of Class B common stock to the Issuer for no consideration, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Person's control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the initial public offering (the "IPO") disclosing all material information about the Issuer and the IPO.
Documents
Issuer
DA32 Life Science Tech Acquisition Corp.
CIK 0001863294
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001871990
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 7:37 PM ET
- Size
- 7.1 KB